Sign In  |  Register  |  About San Anselmo  |  Contact Us

San Anselmo, CA
September 01, 2020 1:33pm
7-Day Forecast | Traffic

  • Search Hotels in San Anselmo

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Danaher Corp (NY: DHR )

271.95 -0.03 (-0.01%)
Streaming Delayed Price Updated: 3:03 PM EDT, Sep 12, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 990,877
Open 271.78
Bid (Size) 271.87 (1)
Ask (Size) 272.07 (7)
Prev. Close 271.98
Today's Range 267.56 - 273.03
52wk Range 182.09 - 281.70
Shares Outstanding 724,000,000
Dividend Yield 0.40%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Unpacking the Latest Options Trading Trends in Danaher
Via Benzinga
$1000 Invested In Danaher 10 Years Ago Would Be Worth This Much Today
Via Benzinga

Performance

YTD
+15.83%
+15.83%
1 Month
+1.78%
+1.78%
3 Month
+2.77%
+2.77%
6 Month
+6.50%
+6.50%
1 Year
+23.53%
+23.53%

More News

Read More
Smart Money Is Betting Big In DHR Options
Via Benzinga
Agilent Technologies Thrives From the Forever Chemicals Crackdown
Via MarketBeat
$1000 Invested In This Stock 10 Years Ago Would Be Worth $5,200 Today
Via Benzinga
The Defensive Sectors And VIX Have NOT Given The All-Clear Signal
Via Talk Markets
Topics Stocks
Exposures US Equities
Behind the Scenes of Danaher's Latest Options Trends
Via Benzinga
$1000 Invested In Danaher 10 Years Ago Would Be Worth This Much Today
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
(DHR) - Analyzing Danaher's Short Interest
Via Benzinga
Jim Cramer Says No To This Health Care Stock, Recommends Holding On To Constellation Energy: 'It's Up A Huge Amount'
Via Benzinga
Biogen, Beckman Coulter and Fujirebio to Collaborate on Blood-Based Biomarkers and Test for Tau Pathology in Alzheimer’s Disease
From Biogen Inc.
Via GlobeNewswire
Demystifying Danaher: Insights From 5 Analyst Reviews
Via Benzinga
Market Whales and Their Recent Bets on DHR Options
Via Benzinga
Universal Health Services & Lockheed Martin Were Among Top 11 Large Cap Stocks That Shined The Brightest Last Week (July 21-July 27): Are The Others In Your Portfolio?
Via Benzinga
Top Stock Reports For Costco, Danaher & ServiceNow
Via Talk Markets
It's Time for Some Enthusiasm for Small-Cap Stocks
Via The Motley Fool
Freeport-McMoRan, Pfizer, Danaher And An Industrial Stock: CNBC's 'Final Trades'
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Here's Why Danaher Stock Surged Today
Via The Motley Fool
Danaher Posts Upbeat Earnings, Joins Spotify, MSCI, Owens & Minor And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
DHR Stock Earnings: Danaher Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Medical Giant Danaher Nears Breakout On This 'Stark Contrast' With A Key Rival
Via Investor's Business Daily
Life Science Giant Danaher's Q2 Earnings Beat Estimates On 'Sustained Positive Momentum In Bioprocessing Business', Maintains Guidance
Via Benzinga
Topics Earnings
Exposures Financial
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanAnselmo.com & California Media Partners, LLC. All rights reserved.